CN108299445B - Synthesis method of 1, 5-azaspiro [2,4] heptane - Google Patents

Synthesis method of 1, 5-azaspiro [2,4] heptane Download PDF

Info

Publication number
CN108299445B
CN108299445B CN201810262528.4A CN201810262528A CN108299445B CN 108299445 B CN108299445 B CN 108299445B CN 201810262528 A CN201810262528 A CN 201810262528A CN 108299445 B CN108299445 B CN 108299445B
Authority
CN
China
Prior art keywords
azaspiro
heptane
reaction
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810262528.4A
Other languages
Chinese (zh)
Other versions
CN108299445A (en
Inventor
徐华栋
刘太上
沈美华
周皓
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou University
Original Assignee
Changzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou University filed Critical Changzhou University
Priority to CN201810262528.4A priority Critical patent/CN108299445B/en
Publication of CN108299445A publication Critical patent/CN108299445A/en
Application granted granted Critical
Publication of CN108299445B publication Critical patent/CN108299445B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a synthesis method of 1, 5-azaspiro [2,4] heptane, which comprises the steps of taking a vinyl azide compound as a raw material, heating the vinyl azide compound in an organic solvent for reaction, and carrying out an Alder alkene reaction on an azapropene intermediate to obtain the required 1, 5-azaspiro [2,4] heptane compound. The preparation method has the advantages of convenient preparation of reaction raw materials, no need of any catalyst and acid-base additive in the reaction, simple operation, quick and easily obtained product and only single cis-configuration.

Description

Synthesis method of 1, 5-azaspiro [2,4] heptane
Technical Field
The invention belongs to the technical field of chemical pharmacy and fine chemical preparation, and particularly relates to a synthesis method of 1, 5-azaspiro [2,4] heptane.
Background
The azaspiro compounds are important organic compounds, and a plurality of natural products and artificial products with azaspiro structures show good biological activity. The anticancer activity of origamin derivatives is reported in US patent (US20160096844a1), which includes compounds of 1-azaspiro [2,4] heptane structure. European patent WO2016182938A1 reports a class of anti-hepatitis C virus compounds, which also include compounds of the 1-azaspiro [2,4] heptane structure. Thus, the 1-azaspiro [2,4] heptane structure has potential biological activity. However, the construction methods of 1-azaspiro [2,4] heptane structures have been so far limited, and the synthetic methods reported in the literature can be summarized as the following two methods:
(1) taking (1-aminocyclopentyl) methanol as a starting material, protonating, dehydrating and cyclizing under an acidic condition to synthesize the 1-azaspiro [2,4] heptane, wherein the synthetic route is shown as an equation A. The method has the disadvantages of severe pollution and difficult industrialization due to the use of strong acid and strong alkali.
Equation a:
Figure BDA0001610603630000011
(2) sulfenimide indolone is used as a starting material, trimethyl sulfoxide iodide is used as a sulfonium oxide salt, NaH is used as an alkali, and sulfur ylide is generated on site to be added with imine to obtain 1, 5-azaspiro [2,4] heptane, wherein the synthetic route is shown as an equation B. The disadvantage is that the reaction also requires the addition of strong bases and the substrates are not easy to prepare.
Equation B:
Figure BDA0001610603630000021
disclosure of Invention
The technical problem to be solved by the invention is as follows: based on the problems, the invention provides a method for synthesizing 1, 5-azaspiro [2,4] heptane.
The technical scheme adopted by the invention for solving the technical problems is as follows: a method for synthesizing 1, 5-azaspiro [2,4] heptane comprises the following steps: under the protection of nitrogen, dissolving vinyl azide compound 1 in an organic solvent, heating for reaction, controlling the reaction temperature and the reaction time, removing the organic solvent by reduced pressure distillation after the reaction is stopped, and separating and purifying the residue by silica gel column chromatography by using ethyl acetate and petroleum ether as eluent to obtain 1, 5-azaspiro [2,4] heptane compound 2.
The synthetic route of the invention is shown in equation (1):
Figure BDA0001610603630000022
further, the general structural formula of the vinyl azide 1 is as follows:
Figure BDA0001610603630000023
wherein R is1Is any one of phenyl, benzyl and p-toluenesulfonyl; when R is2When it is methyl, R3Is any one of hydrogen, methyl, phenyl and chlorine, when R is3When it is methyl, R2Is any one of methyl and phenyl; r2And R3The structure may be a cyclic structure connected end to end, specifically, any of the following structures.
Figure BDA0001610603630000031
Further, 1, 5-azaspiro [2,4]]The structural general formula of the heptane compound 2 is:
Figure BDA0001610603630000032
wherein R is1Is any one of phenyl, benzyl and p-toluenesulfonyl; r4Is any one of the structures shown below.
Figure BDA0001610603630000033
Further, the organic solvent is an aprotic solvent, toluene.
Further, the reaction temperature is 60-120 ℃, and the reaction time is 6-15 hours.
The preparation method of the raw material vinyl azide adopted by the invention is shown as an equation (2):
Figure BDA0001610603630000041
firstly, primary amine s1 and propargyl bromide s2 are utilized to carry out nucleophilic substitution reaction to obtain a series of propargyl amine compounds s 3; then, nucleophilic substitution reaction is carried out on propargylamine compound s3 and allyl bromide s4 containing different substituent groups again to obtain enepropargylamine compound s 5; finally, under the catalysis of silver carbonate, DMSO is used as a solvent, 2 equivalent of water and TMSN are added into s5 at 80 DEG C3And reacting to generate the required raw material vinyl azide 1.
Preparation of 1, 5-azaspiro [2,4] from vinyl azide]Heptane, the reaction mechanism of which is vinyl azide compound 1a, as shown in equation (3), alkenyl azide generates ternary azapropenidine intermediate M under reaction conditions, and the intermediate stereoselectively obtains the final 1, 5-azaspiro [2,4] through intramolecular Alder alkene reaction]Heptane compound 2 a. The cis-structure of the product 2a can be deduced from the characteristics of the ene reaction, while passing through 2a1H-1H COSY two-dimensional spectrum is obtained and proved.
Figure BDA0001610603630000042
The invention has the beneficial effects that: the 1, 5-azaspiro [2,4] heptane compound is prepared by taking a vinyl azide compound as a raw material, heating the vinyl azide compound in an organic solvent for reaction and carrying out an Alder alkene reaction on an azapropene intermediate. The preparation of reaction raw materials is convenient, the reaction does not need any catalyst or acid-base additive, the operation is simple, the product is fast and easy to obtain, and only has single cis-configuration.
Detailed Description
The invention will now be further illustrated by reference to specific examples, which are intended to be illustrative of the invention and are not intended to be a further limitation of the invention.
The reagent used in the invention is prepared by reference to relevant documents, and the solvent is purified and refined.
Example 1
Figure BDA0001610603630000051
10mL of the tube was sealed, and 1a 100mg was weighed, 2mL of toluene was added, and the reaction was carried out for 15 hours at 60 ℃ under vacuum with nitrogen exchange. The reaction was stopped, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography using petroleum ether and ethyl acetate as an eluent to give yellow liquid 2a in a yield of 72%.1H NMR(400MHz,CDCl3)δ7.34–7.25(m,4H),7.25–7.21(m,1H),4.80–4.79(m,1H),4.62(d,J=2.1Hz,1H),3.65–3.56(m,2H),3.00–2.90(m,2H),2.72(d,J=9.6Hz,1H),2.64–2.58(m,2H),1.76(s,3H),1.74(s,1H),1.64(s,1H).13C NMR(100MHz,CDCl3) δ 143.0,138.7,128.8,128.3,127.1,114.6,61.5,60.7,58.5,50.0,41.6,31.3,20.5 HRMS (ESI) m/z theoretical value C15H21N2 +[M+H]+229.1699, found 229.1703.
Example 2
Figure BDA0001610603630000052
10mL of the tube was sealed, and 1b 100mg was weighed, 2mL of toluene was added, and the reaction was carried out for 6 hours at 120 ℃ under vacuum with nitrogen exchange. The reaction was stopped, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography using petroleum ether and ethyl acetate as an eluent to give yellow liquid 2b in 73% yield.1H NMR(400MHz,CDCl3)δ7.33–7.23(m,5H),5.68–5.59(m,1H),5.07(dd,J=10.2,1.8Hz,1H),4.96(dd,J=17.1,1.7Hz,1H),3.62(s,2H),3.06(dd,J=9.1,7.2Hz,1H),2.90(q,J=8.2Hz,1H),2.83(d,J=9.8Hz,1H),2.54(d,J=9.7Hz,1H),2.45(t,J=8.6Hz,1H),1.76(s,1H),1.65(s,1H).13C NMR(75MHz,CDCl3) δ 137.4,134.6,127.9,127.3,126.1,117.2,60.0,59.6,59.3,46.0,41.1,28.7 HRMS (ESI) m/z theoretical value C14H19N2 +[M+H]+215.1543, found 215.1545.
Example 3
Figure BDA0001610603630000061
10mL of the tube was sealed, and 1c 100mg was weighed, 2mL of toluene was added, and the reaction was carried out for 8 hours at 100 ℃ under vacuum with nitrogen exchange. The reaction was stopped, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography using petroleum ether and ethyl acetate as an eluent to give 2c as a yellow liquid in a yield of 79%.1H NMR(400MHz,CDCl3)δ7.42–7.26(m,10H),5.47(s,1H),5.20(s,1H),3.69–3.64(m,3H),3.16(dd,J=9.2,7.4Hz,1H),2.95(d,J=9.7Hz,1H),2.74(d,J=9.8Hz,1H),2.69(t,J=9.0Hz,1H),1.77(s,1H),1.66(s,1H).13C NMR(75MHz,CDCl3) δ 146.2,141.0,138.6,128.8,128.4,128.3,127.8,127.1,126.7,116.7,61.7,60.7,60.4,47.2,42.8,31.2 HRMS (ESI) m/z theoretical value C20H23N2 +[M+H]+291.1856, found 291.1856.
Example 4
Figure BDA0001610603630000071
10mL of the tube was sealed, 1d of 100mg was weighed, 2mL of toluene was added, vacuum was applied and nitrogen was exchanged, and the reaction was carried out at 100 ℃ for 8 hours. The reaction was stopped, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography using petroleum ether and ethyl acetate as an eluent to give 2d as a yellow liquid in a yield of 78%.1H NMR(400MHz,CDCl3)δ7.42–7.32(m,5H),7.28–7.25(m,2H),6.74(t,J=7.3Hz,1H),6.59(d,J=8.2Hz,2H),5.58(s,1H),5.30(s,1H),3.83(t,J=8.2Hz,1H),3.73(s,1H),3.58(dt,J=9.3,3.2Hz,2H),3.45(d,J=9.7Hz,1H),1.78(s,1H),1.71(s,1H),0.63(s,1H).13C NMR(100MHz,CDCl3) δ 147.7,145.2,141.3,129.3,128.7,128.0,126.5,116.4,116.1,111.8,55.1,53.2,46.3,42.8,29.1 HRMS (ESI) m/z theoretical value C19H21N2 +[M+H]+277.1699, found 277.1701.
Example 5
Figure BDA0001610603630000072
10mL of the tube was sealed, and 1e 100mg was weighed, 2mL of toluene was added, vacuum was applied and nitrogen was exchanged, and the reaction was carried out at 100 ℃ for 8 hours. The reaction was stopped, the solvent was distilled off under reduced pressure, and the residue was subjected to silica gel column chromatography and purification using petroleum ether and ethyl acetate as an eluent to give 2e as a yellow liquid in 83% yield.1H NMR(400MHz,CDCl3)δ7.33–7.22(m,5H),5.36(s,1H),3.59(s,2H),2.90–2.88(m,2H),2.72(d,J=9.6Hz,1H),2.57–2.52(m,2H),1.98–1.95(m,4H),1.70–1.68(m,2H),1.66–1.57(m,2H),1.56–1.45(m,2H).13C NMR(75MHz,CDCl3) δ 138.7,134.8,128.9,128.3,127.0,126.5,61.6,60.8,58.0,50.4,41.7,31.4,26.6,25.3,22.8,22.4 HRMS (ESI) m/z theoretical value C18H25N2 +[M+H]+269.2012, found 269.2016.
In light of the foregoing description of the preferred embodiment of the present invention, many modifications and variations will be apparent to those skilled in the art without departing from the spirit and scope of the invention. The technical scope of the present invention is not limited to the content of the specification, and must be determined according to the scope of the claims.

Claims (4)

1. A method for synthesizing 1, 5-azaspiro [2,4] heptane is characterized in that: the synthesis method comprises the following steps: under the protection of nitrogen, dissolving a vinyl azide compound in an organic solvent, heating for reaction, controlling the reaction temperature and the reaction time, removing the organic solvent by reduced pressure distillation after the reaction is stopped, and separating and purifying residues by silica gel column chromatography by using ethyl acetate and petroleum ether as eluent to obtain a1, 5-azaspiro [2,4] heptane compound;
the general structural formula of the vinyl azide is as follows:
Figure DEST_PATH_IMAGE002
wherein R is1Is any one of phenyl, benzyl and p-toluenesulfonyl; when R is2When it is methyl, R3Is any one of hydrogen, methyl, phenyl and chlorine, when R is3When it is methyl, R2Is any one of methyl and phenyl; or R2And R3Is a cyclic structure connected end to end;
the R is2And R3Is a cyclic structure connected end to end, and specifically any one of the following structures:
Figure DEST_PATH_IMAGE004
2. the 1, 5-azaspiro [2,4] of claim 1]The heptane synthesizing process features that: the prepared 1, 5-azaspiro [2, 4%]The structural general formula of the heptane compound is:
Figure DEST_PATH_IMAGE006
wherein R is1Is any one of phenyl, benzyl and p-toluenesulfonyl; r4Is any one of the structures shown below:
Figure DEST_PATH_IMAGE008
3. a process for the synthesis of 1, 5-azaspiro [2,4] heptane as claimed in claim 1 wherein: the solvent is an aprotic solvent toluene.
4. A process for the synthesis of 1, 5-azaspiro [2,4] heptane as claimed in claim 1 wherein: the reaction temperature is 60-120 ℃, and the reaction time is 6-15 h.
CN201810262528.4A 2018-03-28 2018-03-28 Synthesis method of 1, 5-azaspiro [2,4] heptane Active CN108299445B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810262528.4A CN108299445B (en) 2018-03-28 2018-03-28 Synthesis method of 1, 5-azaspiro [2,4] heptane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810262528.4A CN108299445B (en) 2018-03-28 2018-03-28 Synthesis method of 1, 5-azaspiro [2,4] heptane

Publications (2)

Publication Number Publication Date
CN108299445A CN108299445A (en) 2018-07-20
CN108299445B true CN108299445B (en) 2020-03-20

Family

ID=62847954

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810262528.4A Active CN108299445B (en) 2018-03-28 2018-03-28 Synthesis method of 1, 5-azaspiro [2,4] heptane

Country Status (1)

Country Link
CN (1) CN108299445B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102863373B (en) * 2012-09-07 2014-03-12 苏州康润医药有限公司 Method for synthesizing 5-benzylazaspiro[2,4]heptane
CN104628644A (en) * 2015-01-23 2015-05-20 常州大学 3-azabicyclo [4,1,0] heptyl aldehydes and preparation method thereof

Also Published As

Publication number Publication date
CN108299445A (en) 2018-07-20

Similar Documents

Publication Publication Date Title
CN114133350A (en) Preparation method of anti-neocorolla drug Paxlovid intermediate
CN108727244A (en) A kind of method that 1,6- eneynes nitrification cyclization prepares 2-Pyrrolidone class compound
CN107141246B (en) A kind of preparation method of Isatine derivatives
CN108409625A (en) A kind of preparation method of 2-Pyrrolidone class compound
CN111646964B (en) Novel method for synthesizing 2H-pyran-2-one derivative by base catalysis
CN104557957B (en) Synthetic method of spiro-oxoindole ethylene oxide derivative
CN111978229B (en) Synthesis method of dialkyl diselenide compound
CN108299445B (en) Synthesis method of 1, 5-azaspiro [2,4] heptane
CN108440384B (en) Process for the preparation of trifluoromethylated derivatives of isoindolones
CN114293210B (en) Method for continuously electrosynthesis of benzopyran-4-ketone by using micro-reaction device
CN110317170B (en) Green synthesis method of 3-phenanthridinyl propyl formate compound
CN109851599B (en) Preparation method of 2-aminobenzofuran compound
CN111646958B (en) Preparation method of carfilzomib
CN109369618B (en) Method for preparing 2-chloro-5- ((2- (nitromethylene) imidazoline-1-yl) methyl) pyridine in one pot
CN111302971B (en) Method for continuously preparing 5-cyanodiol
CN111499600A (en) Synthesis method of polysubstituted 2, 3-dihydrofuran compound
CN107686460B (en) Preparation method of 3-substituted-3-hydroxy-2-indolone compound
CN109867629B (en) 3-amido-4-acyl pyridazine derivative and synthetic method thereof
CN109384753B (en) Synthetic method of 2-phenyl-3-methylbenzofuran compound
CN111393437A (en) Trisubstituted indolizine compound and preparation method thereof
CN111056915A (en) Synthesis method of 1, 2-dialkyl-1, 2-diaryl acetylene cyclobutane
CN113861093B (en) Synthesis method of polysubstituted gamma-butyrolactam
CN111269155A (en) Method for synthesizing alkenyl sulfone compound under metal-free condition
CN109810056B (en) S-alkyl-S-quinolyl-N-sulfonyl nitrogen sulfur ylide compound and preparation and application thereof
CN112125843B (en) Preparation method of 3-hydroxymethyl-4-phenyl-3, 4-dihydroquinolinone compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant